Literature DB >> 10389756

Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats.

O Engebraaten1, O Fodstad.   

Abstract

Animal models for breast cancer metastasis are valuable tools for studying mechanisms of metastasis and for preclinical testing of anti-metastatic therapy regimens. Using MA-11 and MT-1, two oestrogen and progesterone receptor-negative human breast cancer cell lines, we developed new models in nude rats with patterns of experimental metastasis resembling those frequently observed in humans. MA-11 cells showed a clear preference for growth in the CNS. Fourteen of 15 animals injected with MA-11 cells into the left ventricle of the heart developed hind-leg paralysis, and tumours were observed in the spinal cord. MT-1 cells consistently exhibited bone/bone marrow metastases after intracardial injection, in addition to tumours in the brain and spinal cord. When injected into the cisterna magna, both cell lines gave rise to leptomeningeal neoplastic disease. Injection of MA-11 cells into the tibial bone marrow resulted in tumours in only 2 of 13 rats, whereas all animals injected with MT-1 cells developed tumours. Only 2 of 6 rats injected i.v. with MA-11 cells developed lung colonies compared with all 9 animals injected with MT-1 cells. Cell-surface expression of the following was examined: EGP2; MUC1; EGFr; E- and N-cadherin; the alpha2, alpha3, alpha5, beta1 and beta4 integrins; c-erb-B2; and N-CAM. c-erb-B2 was expressed in a higher percentage of the bone-metastasizing MT-1 cells than the MA-11 cells, whereas E-cadherin was expressed in MA-11 but not MT-1 cells. In animals injected with MA-11 and MT-1 cells in the left cardiac ventricle, treatment with cisplatin and doxorubicin did not improve survival. In summary, these clinically relevant animal models may be used for studies related to site-specific growth and metastasis and for assessing effects of experimental therapy against human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389756     DOI: 10.1002/(sici)1097-0215(19990719)82:2<219::aid-ijc12>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Preclinical approaches to study the biology and treatment of brain metastases.

Authors:  William Cruz-Muñoz; Robert S Kerbel
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

2.  Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis.

Authors:  Zina Jeyapalan; Zhaoqun Deng; Tatiana Shatseva; Ling Fang; Chengyan He; Burton B Yang
Journal:  Nucleic Acids Res       Date:  2010-12-10       Impact factor: 16.971

3.  Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.

Authors:  Germana Rappa; Aurelio Lorico
Journal:  Exp Cell Res       Date:  2010-01-11       Impact factor: 3.905

4.  Phenotypic heterogeneity of breast cancer stem cells.

Authors:  Aurelio Lorico; Germana Rappa
Journal:  J Oncol       Date:  2011-01-17       Impact factor: 4.375

5.  Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Authors:  Zannel Blanchard; Nicole Mullins; Pavani Ellipeddi; Janice M Lage; Shawn McKinney; Rana El-Etriby; Xu Zhang; Raphael Isokpehi; Brenda Hernandez; Wael M Elshamy
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

Review 6.  Canine mammary tumors as a model for human disease.

Authors:  Somaia M Abdelmegeed; Sulma Mohammed
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

7.  Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.

Authors:  Y Andersson; O Engebraaten; Ø Fodstad
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

8.  Anticancer activity of Amauroderma rude.

Authors:  Chunwei Jiao; Yi-Zhen Xie; Xiangling Yang; Haoran Li; Xiang-Min Li; Hong-Hui Pan; Mian-Hua Cai; Hua-Mei Zhong; Burton B Yang
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.

Authors:  Albert J M Yee; Margarete Akens; Bing L Yang; Joel Finkelstein; Peng-Sheng Zheng; Zhaoqiong Deng; Burton Yang
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.